文献速递腹部CTMRUS

CT/MRI LI-RADS联合CEUS可提高肝细胞癌的诊断效能

Combination of CT/MRI LI-RADS with CEUS can improve the diagnostic performance for HCCs.
PubMed 文献 · Eur J Radiol · 2022-02-09

本研究纳入213个直径小于3 cm的局灶性肝脏病变,比较CEUS LI-RADS v2017与CT/MRI LI-RADS v2018分类的一致性及对HCC的诊断效能;结果显示两种分类一致性差(kappa=0.254),CT/MRI LR-3和LR-4的HCC阳性预测值高于CEUS相应分级,用CEUS对CT/MRI LR-3和LR-4病变重新分类有助于HCC的明确诊断。

要点

  • CT/MRI与CEUS LI-RADS分类一致性差,kappa值仅0.254(P<0.001)。
  • CT/MRI LR-3和LR-4的HCC阳性预测值分别为57.1%和75.0%,高于CEUS LR-3的37.5%和LR-4的56.0%。
  • 用CEUS对CT/MRI LR-3和LR-4病变重新分类,有助于相应HCC获得明确诊断。

核心结论

  • CT/MRI LR-3和LR-4病变的HCC概率分别高于CEUS LR-3和LR-4;用CEUS对CT/MRI LR-3和LR-4病变重新分类有助于相应HCC获得明确诊断。

研究设计与样本

  • 研究纳入1个月内行CEUS和CT/MRI(MR需在3.0 T磁体上进行)的直径小于3 cm的局灶性肝脏病变,共213个病变;每个结节分别按CEUS LI-RADS v2017(usLI-RADS)和CT/MRI LI-RADS v2018分类,评估两种分类的组间一致性并分析分类不一致的原因。

诊断标准与关键数值

  • CT/MRI LI-RADS LR-3、LR-4、LR-5的HCC阳性预测值分别为57.1%(95% CI: 32.6-78.6)、75.0%(95% CI: 62.3-84.5)、94.2%(95% CI: 88.9-97.0)。
  • CEUS LI-RADS LR-3、LR-4、LR-5的HCC阳性预测值分别为37.5%(95% CI: 18.5-61.4)、56.0%(95% CI: 37.1-73.3)、97.9%(95% CI: 94.1-99.3)。
  • CT/MRI与CEUS LI-RADS分类一致性差,kappa值为0.254(P<0.001)。
  • 84个病变(39.4%)在CT/MRI与CEUS LI-RADS间分类不一致;其中40个CT/MRI分类为LR-3或LR-4的病变被CEUS升级,21个CT/MRI分类为LR-4或LR-5的病变被CEUS降级。
  • 用CEUS对CT/MRI LR-3和LR-4病变重新分类后,重新分类的LR-3、LR-4、LR-5的HCC阳性预测值分别为27.3%(95% CI: 9.7-56.6)、41.7%(95% CI: 26.2-69.0)、94.2%(95% CI: 89.3-97.0),降低了CT/MRI LR-3和LR-4中HCC的发生率。

临床应用与阅片要点

  • 对CT/MRI分类为LR-3或LR-4的直径小于3 cm局灶性肝脏病变,可参考CEUS LI-RADS重新分类以辅助HCC明确诊断(作者结论)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND &amp; AIMS: To compare the classifications for focal liver lesions smaller than 3 cm by the CEUS and CT/MRI LI-RADS and explore the discrepancy between the two classifications strategies.

METHODS: Focal liver lesions with a size smaller than 3 cm undergoing CEUS and CT/MRI (MR required on a 3.0 T magnet) within 1 month were enrolled. Each nodule was categorized according to the CEUS LI-RADS v2017 (usLI-RADS) and CT/MRI LI-RADS v2018. Intermodality agreement between the usLI-RADS and LI-RADS for CT/MRI was assessed. The reasons for inconsistent classifications by the CEUS and CT/MRI LI-RADS were clarified.

RESULTS: A total of 213 lesions were included. The positive predictive value (PPV) for HCCs of LR-3, 4 and 5 were 57.1% (95% CI: 32.6-78.6), 75.0% (95% CI: 62.3-84.5) and 94.2% (95% CI: 88.9-97.0) for CT/MRI and 37.5% (95% CI: 18.5-61.4), 56.0% (95% CI: 37.1-73.3) and 97.9% (95% CI: 94.1-99.3) for CEUS, respectively. CECT/MRI and CEUS LI-RADS had a poor agreement in classification with a kappa value of 0.254 (P < 0.001). 84 lesions (39.4%) were classified inconsistently in CT/MRI and CEUS LI-RADS. 40 lesions classified as LR-3 or LR-4 by CT/MRI were upgraded by CEUS. 21 lesions classified as LR-4 or LR-5 by CT/MRI were downgraded by CEUS. We reclassified the lesion in CT/MRI LR-3 and LR-4 by CEUS. The PPVs for HCCs in reclassified LR-3, LR-4 and LR-5 were 27.3% (95% CI: 9.7-56.6), 41.7% (95% CI: 26.2-69.0) and 94.2% (95% CI: 89.3-97.0), respectively, which decreased the incidences of HCCs in CT/MRI LR-3 and LR-4.

CONCLUSION: Lesions in CT/MRI LR-3 and 4 have a higher probability of being HCCs than those in usLR-3 and 4, respectively. Reclassification of lesions in CT/MRI LR-3 and 4 using CEUS can help the corresponding HCCs get a definite diagnosis.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhou, Ding, Qin, et al. Combination of CT/MRI LI-RADS with CEUS can improve the diagnostic performance for HCCs. Eur J Radiol. 2022. PMID: 35196614. doi:10.1016/j.ejrad.2022.110199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。